Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Non-Current Assets: 2020-2023

Historic Other Non-Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $300,000.

  • Candel Therapeutics' Other Non-Current Assets rose 12.78% to $300,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $300,000, marking a year-over-year increase of 12.78%. This contributed to the annual value of $300,000 for FY2022, which is 29.25% down from last year.
  • Per Candel Therapeutics' latest filing, its Other Non-Current Assets stood at $300,000 for Q3 2023, which was down 0.00% from $300,000 recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Other Non-Current Assets ranged from a high of $1.7 million in Q2 2021 and a low of $266,000 during Q2 2022.
  • Moreover, its 3-year median value for Other Non-Current Assets was $300,000 (2023), whereas its average is $472,800.
  • Per our database at Business Quant, Candel Therapeutics' Other Non-Current Assets grew by 21.49% in 2021 and then plummeted by 84.46% in 2022.
  • Candel Therapeutics' Other Non-Current Assets (Quarterly) stood at $349,000 in 2020, then grew by 21.49% to $424,000 in 2021, then fell by 29.25% to $300,000 in 2022, then increased by 12.78% to $300,000 in 2023.
  • Its last three reported values are $300,000 in Q3 2023, $300,000 for Q2 2023, and $300,000 during Q1 2023.